Join us in London on 4 July 2026 to celebrate 30 years of our Cochrane Group2026 marks 30 years of the Cochrane Gynaecology and Fertility Group.We invite you to join us and colleagues from Cochrane’s Sexual and Reproductive Health Thematic Group for an all-day celebration and symposium on Saturday, July 4 2026.More information will be available soon. 

September is Polycystic Ovary Syndrome Awareness Month  

Controlled ovarian stimulation (COS) is an essential step in most assisted conception cycles.

A new international guideline for outcome reporting in male infertility clinical trials has been developed by a team of clinicians, researchers and people with lived experiences of infertility. This work will enable researchers to plan future clinical trials so their results can be more easily compared and we understand sooner, which treatments are effective for male infertility.

A new website developed by researchers at the University of Melbourne, in collaboration with Cochrane, is helping IVF patients navigate the complex and often confusing world of optional treatment add-ons.​ 

Can vasodilators (medicines that widen blood vessels) help women with infertility have children?For women undergoing fertility treatment, it is important to ensure the blastocyst can implant normally in the endometrium. There are many medicines that could increase rates of implantation and live births. These include vasodilators, which dilate blood vessels to thicken the endometrium and help the womb relax, among other effects that could make the womb more receptive to the blastocyst.

March is Endometriosis Awareness Month. Endometriosis is an inflammatory condition where endometrial tissue (tissue similar to the lining of the uterus) grows outside of the uterus. It is estimated that 1 in 10 women have endometriosis (Zondervan 2020).Endometriosis frequently presents with the symptom of pain including dysmenorrhoea (painful periods), dyspareunia (pain during sexual intercourse), and chronic pelvic or abdominal pain.